Literature DB >> 2462290

Striatal dopamine in acute cerebral ischemia of stroke-resistant rats.

T Kawano1, K Tsutsumi, H Miyake, K Mori.   

Abstract

We devised the present experiments to assess the effects of ischemia on the production of dopamine in the caudate nucleus of spontaneously hypertensive stroke-resistant rats. Ringer's solution was continuously perfused at a rate of 10 microliters/min through 0.2-mm-diameter dialysis tubing implanted in the rat's caudate nucleus. After bilateral occlusion of the common carotid artery, perfusate was collected at 20-minute intervals for 120 minutes and was analyzed for monoamines and their metabolites using high-performance liquid chromatography and an electrochemical detection system. The extracellular concentration of dopamine increased abruptly approximately 3 minutes after the ischemic insult, reached a maximum at between 20 and 40 minutes after the insult, and subsequently decreased. During the 120 minutes, 3,4-dihydroxyphenylacetic acid and 5-hydroxyindole-3-acetic acid concentrations decreased significantly, whereas 5-hydroxytryptamine was not detected. Our results indicate that during cerebral ischemia a large increase in extracellular dopamine concentration in the caudate nucleus occurs, probably as a result of energy failure of the cell membranes. This leakage of dopamine may be a causal factor in the neuronal damage associated with cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2462290     DOI: 10.1161/01.str.19.12.1540

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  8 in total

1.  Ischemic flow threshold for striatal dopamine release in rats.

Authors:  H Yao; H Ooboshi; S Sadoshima; K Takano; S Ibayashi; M Fujishima
Journal:  Neurochem Res       Date:  1990-05       Impact factor: 3.996

2.  Changes in monoaminergic neuronal function in the lower brain stem following subarachnoid hemorrhage induced in rats.

Authors:  K Hirata; T Kawano; K Mori
Journal:  Cell Mol Neurobiol       Date:  1993-12       Impact factor: 5.046

3.  Characterization of phenytoin, carbamazepine, vinpocetine and clorgyline simultaneous effects on sodium channels and catecholamine metabolism in rat striatal nerve endings.

Authors:  María Sitges; Blanca I Aldana; Luz M Chiu; Vladimir Nekrassov
Journal:  Neurochem Res       Date:  2008-08-19       Impact factor: 3.996

4.  Curcumin reverses neurochemical, histological and immuno-histochemical alterations in the model of global brain ischemia.

Authors:  Glaura Fernandes Teixeira de Alcântara; Eudes Simões-Neto; Giovany Michely Pinto da Cruz; Maria Elizabeth Pereira Nobre; Kelly Rose Tavares Neves; Geanne Matos de Andrade; Gerly Anne de Castro Brito; Glauce Socorro de Barros Viana
Journal:  J Tradit Complement Med       Date:  2016-02-11

5.  Exercise on Striatal Dopamine Level and Anxiety-Like Behavior in Male Rats after 2-VO Cerebral Ischemia.

Authors:  Yongzhao Fan; Xiaoyang Kong; Kun Liu; Hao Wu
Journal:  Behav Neurol       Date:  2022-09-13       Impact factor: 3.112

6.  Omega-3 Fatty Acids: Possible Neuroprotective Mechanisms in the Model of Global Ischemia in Rats.

Authors:  Maria Elizabeth Pereira Nobre; Alyne Oliveira Correia; Francisco Nilson Maciel Mendonça; Luiz Ricardo Araújo Uchoa; Jessica Tamara Nunes Vasconcelos; Carlos Ney Alencar de Araújo; Gerly Anne de Castro Brito; Rafaelly Maria Pinheiro Siqueira; Gilberto Dos Santos Cerqueira; Kelly Rose Tavares Neves; Ricardo Mário Arida; Glauce Socorro de Barros Viana
Journal:  J Nutr Metab       Date:  2016-05-24

Review 7.  The Intersection of Central Dopamine System and Stroke: Potential Avenues Aiming at Enhancement of Motor Recovery.

Authors:  Annette Gower; Mario Tiberi
Journal:  Front Synaptic Neurosci       Date:  2018-07-06

8.  Global Cerebral Ischemia in Male Long Evans Rats Impairs Dopaminergic/ΔFosB Signalling in the Mesocorticolimbic Pathway Without Altering Delay Discounting Rates.

Authors:  Alexandre Morin; Marilou Poitras; Hélène Plamondon
Journal:  Front Behav Neurosci       Date:  2022-01-04       Impact factor: 3.558

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.